Figure 3From: Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myelomaKaplan-Meier survival analysis (months) showing difference in patients survival (when plasma cell count divided in high and low groups according the median) obtained by (a) pathologist report (BMB) ( P = 0.0341), (b) computer-assisted (CIA) report ( P = 0.013), and (c) cytologist (BMA) report ( P = 0.05), when cut off for atypical plasma cell count was set at 25%.Back to article page